Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-Blocker Evaluation in Survival Trial
NCT00000560Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1994
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bucindolol in heart failure (HF), sponsored by National Heart, Lung, and Blood Institute. Started Jun 1994; status: completed.
02
Drugs
bucindolol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00000560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000560.